HRP20141004T1 - Novi postupak pripreme estera skopina - Google Patents
Novi postupak pripreme estera skopina Download PDFInfo
- Publication number
- HRP20141004T1 HRP20141004T1 HRP20141004AT HRP20141004T HRP20141004T1 HR P20141004 T1 HRP20141004 T1 HR P20141004T1 HR P20141004A T HRP20141004A T HR P20141004AT HR P20141004 T HRP20141004 T HR P20141004T HR P20141004 T1 HRP20141004 T1 HR P20141004T1
- Authority
- HR
- Croatia
- Prior art keywords
- optionally
- alkyl
- aryl
- group
- scopine
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 9
- FIMXSEMBHGTNKT-RZVDLVGDSA-N scopine Chemical class C([C@@H]1N2C)[C@H](O)C[C@@H]2[C@@H]2[C@H]1O2 FIMXSEMBHGTNKT-RZVDLVGDSA-N 0.000 title claims 4
- 238000002360 preparation method Methods 0.000 title claims 2
- 150000003839 salts Chemical group 0.000 claims 7
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 claims 6
- FIMXSEMBHGTNKT-UHFFFAOYSA-N Scopine Natural products CN1C2CC(O)CC1C1C2O1 FIMXSEMBHGTNKT-UHFFFAOYSA-N 0.000 claims 6
- 125000003118 aryl group Chemical group 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 239000002585 base Substances 0.000 claims 5
- -1 scopine ester Chemical class 0.000 claims 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 4
- 125000005024 alkenyl aryl group Chemical group 0.000 claims 4
- 125000000217 alkyl group Chemical group 0.000 claims 4
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 4
- 229910052760 oxygen Inorganic materials 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims 3
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 3
- 239000004215 Carbon black (E152) Substances 0.000 claims 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 3
- 125000002877 alkyl aryl group Chemical group 0.000 claims 3
- 125000000304 alkynyl group Chemical group 0.000 claims 3
- 125000005018 aryl alkenyl group Chemical group 0.000 claims 3
- 125000003710 aryl alkyl group Chemical group 0.000 claims 3
- 125000005015 aryl alkynyl group Chemical group 0.000 claims 3
- 125000004122 cyclic group Chemical group 0.000 claims 3
- 229930195733 hydrocarbon Natural products 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- 125000003107 substituted aryl group Chemical group 0.000 claims 3
- 238000005809 transesterification reaction Methods 0.000 claims 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 2
- 125000005025 alkynylaryl group Chemical group 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims 2
- 125000001188 haloalkyl group Chemical group 0.000 claims 2
- 150000002430 hydrocarbons Chemical class 0.000 claims 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 claims 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 claims 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical group CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 claims 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 claims 1
- 101100219382 Caenorhabditis elegans cah-2 gene Proteins 0.000 claims 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical group CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 150000001733 carboxylic acid esters Chemical class 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000012458 free base Substances 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 238000004128 high performance liquid chromatography Methods 0.000 claims 1
- 150000004678 hydrides Chemical class 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- 150000007529 inorganic bases Chemical class 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 229930195734 saturated hydrocarbon Natural products 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 125000005270 trialkylamine group Chemical group 0.000 claims 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 claims 1
- 125000002827 triflate group Chemical group FC(S(=O)(=O)O*)(F)F 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D451/06—Oxygen atoms
- C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Claims (8)
1. Postupak pripreme estera skopina I ili njegove kvartarne soli II:
[image]
koji obuhvaća transesterifikaciju skopina, ili njegove adicijske soli od mineralne kiseline ili organske kiseline, s prikladnim karboksilnim esterom formule R1CO2R3; gdje R1 i R2 nezavisno predstavljaju vodik, alkil, alkenil, alkenil, po izboru supstituirani aril, ili po izboru supstituirani arilalkil, arilalkenil, arilalkinil, alkilaril, alkenilaril ili alkinilaril; R3 predstavlja alkil, alkenil, alkinil, po izboru supstituirani aril, ili po izboru supstituirani arilalkil, arilalkenil, arilalkinil, alkilaril, alkenilaril ili alkenilaril; i X predstavlja farmaceutski prikladan; gdje se reakcija transesterifikacije provodi u prisutnosti organske aminske baze;
gdje je "alkil" skupina monovalentni zasićeni ugljikovodik, koji može biti ravnolančani ili razgranat, ili može biti ili obuhvaćati cikličke skupine, i po izboru može biti supstituiran, i po izboru može obuhvaćati jedan ili više heteroatoma N, O ili S u svom ugljikovom kosturu;
gdje je "alkenil" skupina monovalentni ugljikovodik, koji ima barem jednu dvostruku ugljik-ugljik vezu, i koji može biti ravnolančani ili razgranat, ili može biti ili obuhvaćati cikličke skupine, i po izboru može biti supstituiran, i po izboru može obuhvaćati jedan ili više heteroatoma N, O ili S u svom ugljikovom kosturu;
gdje je "alkinil" skupina monovalentni ugljikovodik, koji ima barem jednu trostruku ugljik-ugljik vezu, i koji može biti ravnolančani ili razgranat, ili može biti ili obuhvaćati cikličke skupine, i po izboru može biti supstituiran, i po izboru može obuhvaćati jedan ili više heteroatoma N, O ili S u svom ugljikovom kosturu; i
gdje je "aril" skupina monovalentni aromatski ugljikovodik, koji po izboru može biti supstituiran, i koji po izboru može obuhvaćati jedan ili više heteroatoma N, O ili S u svom ugljikovom kosturu.
2. Postupak prema zahtjevu 1, gdje:
(i) R1 je predstavljen formulom III:
[image]
gdje R4, R5 i R6 nezavisno predstavljaju vodik, hidroksi, halo, alkoksi, alkil, hidroksialkil, alkenil, alkinil, po izboru supstituirani aril, ili po izboru supstituirani arilalkil, arilalkenil, arilalkinil, alkilaril, alkenilaril ili alkinilaril; i/ili
(ii) R7 predstavlja vodik ili C1-C4 alkil; i/ili
(iii) R3 predstavlja C1-C4 alkil; i/ili
(iv) R3 predstavlja metil; i/ili
(v) X predstavlja halo, metansulfonat, toluensulfonat ili trifluorometansulfonat skupinu; i/ili
(vi) X predstavlja bromo skupinu; i/ili
(vii) R2 je metil i X je brom.
3. Postupak prema zahtjevu 2, gdje:
(i) R4 i/ili R5 predstavljaju aril; i/ili
(ii) R4 i/ili R5 predstavljaju aril, i gdje se arilna skupina izabire između fenila, naftila, tienila i furila, koji po izboru mogu biti mono- ili disupstituirani jednom ili dvije skupine izabrane između C1-C4 alkil, C1-C4 alkoksi, hidroksi, halo ili haloalkil; i/ili
(iii) R4 i/ili R5 predstavljaju aril, i gdje je arilna skupina 2-tienil; i/ili
(iv) R6 predstavlja hidroksi, C1-C4 alkil, C1-C4 alkoksi, hidroksialkil, halo ili haloalkil; i/ili
(v) R4 je 2-tienil, R5 je 2-tienil i R6 je hidroksil.
4. Postupak prema bilo kojem od prethodnih zahtjeva, gdje je organska aminska baza:
(i) trialkilamin ili heterociklički amin; i/ili
(ii) izabrana između trietilamina, diizopropiletilamina, 1,8-diazabiciklo[5.4.0]undec-7-ena (DBU), 1,5-diazabiciklo[4.3.0]non-5-ena (DBN), 1,4-diazabiciklo[2.2.2]oktana (Dabco), piridina ili 4-(dimetilamino)piridina (DMAP); i/ili
(iii) DBU.
5. Postupak prema bilo kojem od prethodnih zahtjeva, gdje se koristi dodatna baza.
6. Postupak prema zahtjevu 5, gdje dodatna baza jest:
(i) anorganska baza; i/ili
(ii) hidrid; i/ili
(iii) NaH, KH ili CaH2; i/ili
(iv) NaH.
7. Postupak prema zahtjevu 5 ili 6, gdje se skopin:
(i) koristi u obliku soli; i/ili
(ii) koristi u obliku soli, i gdje se dodatna baza koristi za oslobađanje slobodne baze skopina in situ.
8. Postupak prema bilo kojem od prethodnih zahtjeva, gdje:
(i) skopin se koristi u obliku svoje ugljikovodične soli;
(ii) stvaranje kvartarne soli II provodi se bez pročišćavanja i/ili izolacije estera I; i/ili
(iii) reakcija transesterifikacije se provodi u dimetilformamidu; i/ili
(iv) ester skopina I ili njegova kvartarna sol II dobivaju se u HPLC čistoći većoj od 95%; i/ili
(v) ester skopina I ili njegova kvartarna sol II dobivaju se u prinosu većem od 50%.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN77KO2008 | 2008-01-10 | ||
| PCT/GB2009/050014 WO2009087419A1 (en) | 2008-01-10 | 2009-01-09 | Novel process for the preparation of scopine esters |
| EP09701042.5A EP2240477B8 (en) | 2008-01-10 | 2009-01-09 | Novel process for the preparation of scopine esters |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20141004T1 true HRP20141004T1 (hr) | 2015-02-13 |
Family
ID=40451439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20141004AT HRP20141004T1 (hr) | 2008-01-10 | 2014-10-20 | Novi postupak pripreme estera skopina |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20110028508A1 (hr) |
| EP (1) | EP2240477B8 (hr) |
| JP (2) | JP6087492B2 (hr) |
| CN (2) | CN101918401A (hr) |
| AU (1) | AU2009203579B2 (hr) |
| CA (1) | CA2710523C (hr) |
| CY (1) | CY1116076T1 (hr) |
| DK (1) | DK2240477T3 (hr) |
| ES (1) | ES2523695T3 (hr) |
| HR (1) | HRP20141004T1 (hr) |
| PL (1) | PL2240477T3 (hr) |
| PT (1) | PT2240477E (hr) |
| SI (1) | SI2240477T1 (hr) |
| WO (1) | WO2009087419A1 (hr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080051582A1 (en) | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| CA2931876A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| WO2011015884A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Process to prepare scopine esters |
| WO2011095800A2 (en) | 2010-02-02 | 2011-08-11 | Generics [Uk] Limited | Analytical methods |
| TR201005222A2 (tr) * | 2010-04-01 | 2011-10-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür sentez yöntemi |
| US8957209B2 (en) * | 2010-04-01 | 2015-02-17 | Mahmut Bilgic | Methods for the synthesis of tiotropium bromide |
| TR201005221A2 (tr) * | 2010-04-01 | 2012-01-23 | Bi̇lgi̇ç Mahmut | Geliştirilmiş sentez metodu. |
| TR201002520A2 (tr) * | 2010-04-01 | 2010-05-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür imalat metodu. |
| CN101979391B (zh) * | 2010-11-16 | 2013-06-05 | 济南德信佳生物科技有限公司 | 一种噻托溴铵的制备方法 |
| US8680297B2 (en) * | 2011-10-06 | 2014-03-25 | Drug Process Licensing Assoc., LLC | Manufacturing process for tiotropium bromide |
| PT106142B (pt) * | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| CZ304808B6 (cs) | 2012-03-16 | 2014-11-05 | Zentiva, K.S. | Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu a jeho nová forma |
| CZ305012B6 (cs) | 2012-03-30 | 2015-03-25 | Zentiva, K.S. | Způsob přípravy skopinesteru kyseliny di(2-thienyl)glykolové, intermediátu v syntéze tiotropium bromidu |
| WO2014140318A1 (en) * | 2013-03-14 | 2014-09-18 | K.H.S. Pharma Holding Gmbh | Improved process for acyl transfer reactions |
| CN117486893B (zh) * | 2023-12-29 | 2024-03-12 | 北京中医药大学深圳医院(龙岗) | anti-pso B及其在制备预防和/或治疗银屑病的药物中的应用 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610163A (en) * | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| DE3931041C2 (de) * | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US6908928B2 (en) * | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| US6506900B1 (en) * | 2001-01-31 | 2003-01-14 | Boehringer Ingelheim Pharma Ag | Process for preparing a scopine ester intermediate |
| AUPR315301A0 (en) * | 2001-02-19 | 2001-03-15 | Silverbrook Research Pty. Ltd. | An Apparatus (ART102) |
| US6608055B2 (en) * | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6610849B2 (en) * | 2001-06-28 | 2003-08-26 | Boehringer Ingelheim Pharma Kg | Process for the manufacture of tropenol |
| DE10200943A1 (de) * | 2002-01-12 | 2003-07-24 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung von Scopinestern |
| US6747153B2 (en) * | 2002-05-31 | 2004-06-08 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Industrial process for preparing tropenol |
| ATE435862T1 (de) * | 2003-05-28 | 2009-07-15 | Theravance Inc | Azabicycloalkanverbindungen als muscarinrezeptor antagonisten |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| ES2393794T3 (es) * | 2005-05-02 | 2012-12-28 | Boehringer Ingelheim International Gmbh | Nuevas formas cristalinas de bromuro de tiotropio |
| DE102005035112A1 (de) * | 2005-07-27 | 2007-02-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen |
| US8163913B2 (en) * | 2005-12-19 | 2012-04-24 | Sicor Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| US20070167480A1 (en) * | 2005-12-19 | 2007-07-19 | Sicor Inc. | Pure and stable tiotropium bromide |
| US20080051582A1 (en) * | 2006-07-10 | 2008-02-28 | Sicor Inc. | Process for the preparation of tiotropium bromide |
| WO2008089852A1 (de) * | 2007-01-26 | 2008-07-31 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Neues verfahren zur herstellung von tiotropiumsalzen |
| WO2008104955A1 (en) * | 2007-02-28 | 2008-09-04 | Ranbaxy Laboratories Limited | Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists |
-
2009
- 2009-01-09 JP JP2010541849A patent/JP6087492B2/ja not_active Expired - Fee Related
- 2009-01-09 CN CN2009801017774A patent/CN101918401A/zh active Pending
- 2009-01-09 PT PT97010425T patent/PT2240477E/pt unknown
- 2009-01-09 AU AU2009203579A patent/AU2009203579B2/en not_active Ceased
- 2009-01-09 CN CN201610056741.0A patent/CN105601628A/zh active Pending
- 2009-01-09 PL PL09701042T patent/PL2240477T3/pl unknown
- 2009-01-09 EP EP09701042.5A patent/EP2240477B8/en active Active
- 2009-01-09 DK DK09701042.5T patent/DK2240477T3/en active
- 2009-01-09 ES ES09701042.5T patent/ES2523695T3/es active Active
- 2009-01-09 SI SI200931062T patent/SI2240477T1/sl unknown
- 2009-01-09 US US12/810,231 patent/US20110028508A1/en not_active Abandoned
- 2009-01-09 WO PCT/GB2009/050014 patent/WO2009087419A1/en active Application Filing
- 2009-01-09 CA CA2710523A patent/CA2710523C/en not_active Expired - Fee Related
-
2014
- 2014-08-15 JP JP2014165472A patent/JP5902774B2/ja not_active Expired - Fee Related
- 2014-10-20 HR HRP20141004AT patent/HRP20141004T1/hr unknown
- 2014-11-11 CY CY20141100937T patent/CY1116076T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2523695T3 (es) | 2014-11-28 |
| PT2240477E (pt) | 2014-11-19 |
| JP5902774B2 (ja) | 2016-04-13 |
| WO2009087419A1 (en) | 2009-07-16 |
| EP2240477A1 (en) | 2010-10-20 |
| CN105601628A (zh) | 2016-05-25 |
| JP2011509284A (ja) | 2011-03-24 |
| AU2009203579A1 (en) | 2009-07-16 |
| US20110028508A1 (en) | 2011-02-03 |
| AU2009203579B2 (en) | 2013-07-25 |
| JP6087492B2 (ja) | 2017-03-01 |
| DK2240477T3 (en) | 2014-12-08 |
| EP2240477B8 (en) | 2014-12-10 |
| SI2240477T1 (sl) | 2015-02-27 |
| CA2710523C (en) | 2014-11-18 |
| CA2710523A1 (en) | 2009-07-16 |
| JP2014208718A (ja) | 2014-11-06 |
| PL2240477T3 (pl) | 2015-03-31 |
| EP2240477B1 (en) | 2014-09-10 |
| CY1116076T1 (el) | 2017-02-08 |
| CN101918401A (zh) | 2010-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20141004T1 (hr) | Novi postupak pripreme estera skopina | |
| ES2587738T3 (es) | Derivados de quinoxalina y quinolina como inhibidores de quinasa | |
| ES2554689T3 (es) | Compuestos farmacéuticos | |
| CO6140053A2 (es) | Proceso para fabricar 2-amino-5-halobenzamidas 3-sustituidas | |
| RU2663999C2 (ru) | Конденсированное гетероциклическое соединение, способ его получения, его фармацевтическая композиция и применения | |
| BRPI0610150A2 (pt) | composto, pró-droga, processo para produzir o composto, composição farmacêutica, antagonista do receptor de crf, e, uso do antagonista do receptor de crf | |
| ES2551557T3 (es) | Pirimidin-4-carboxamidas cíclicas como antagonistas del receptor CCR2 para el tratamiento de inflamaciones, asma y EPOC | |
| ATE480517T1 (de) | Verfahren zur herstellung und reinigung von 2- hydrocarbyl-3,3-bis(4-hydroxyaryl-phthalimidin- monomeren | |
| AR076765A1 (es) | Compuestos antivirales | |
| WO2008146871A1 (ja) | グルココルチコイド受容体結合活性を有する、スルホン酸エステル又はスルホン酸アミド構造を導入したフェニル基を置換基として有する新規１，２，３，４－テトラヒドロキノキサリン誘導体 | |
| HK1169984A1 (en) | Diphenyl-pyrazolopyridine compounds, their preparation and their application as modulators of the nuclear receptor not | |
| MX2009012602A (es) | Proceso para la produccion de pirazoles. | |
| JP2013528200A5 (hr) | ||
| AR084864A1 (es) | Proceso de preparacion de girasa e inhibidores de topoisomerasa iv y compuestos intermediarios de dicho proceso | |
| DE102010040234A1 (de) | Verfahren zur Herstellung von 5-Flour-1H-pyrazolo[3,4-b]pyridin-3-carbonitril | |
| PE20120223A1 (es) | Compuestos heterociclicos como inhibidores del transportador de glicina-1 (glyt-1) | |
| Przewloka et al. | Application of DMF–methyl sulfate adduct in the regioselective synthesis of 3-acylated indolizines | |
| HRP20150617T1 (hr) | Asimetriäśni postupak redukcije | |
| ES2572261T3 (es) | Nuevos compuestos como inhibidores de diacilglicerol aciltransferasa | |
| HRP20160407T1 (hr) | Postupak za pripravu skopin estera di-(2-tienil) glikolne kiseline, međuprodukta u sintezi tiotropij bromida | |
| CN105061467A (zh) | 一种帕克替尼的制备方法 | |
| EA201290481A1 (ru) | Способ получения гидрохлорида прасугреля в полиморфной форме в | |
| CN105017282A (zh) | 帕克替尼的制备方法 | |
| Xia et al. | Controlling chemoselectivity—application of DMF di-t-butyl acetal in the regioselective synthesis of 3-monosubstituted indolizines | |
| NO20064686L (no) | Fremgangsmate for produksjon av kirale, sekundaere alkoholer |